HOME > SERVICES & CAPABILITIES > IN VIVO
At RxCelerate, our in vivo capabilities are extensive and cover diverse disease areas.
Our routine animal models are industry-standard, accompanied by comprehensive comparator data with approved compounds. RxCelerate refined models have built on industry-standards, creating more fit-for-purpose experimental paradigms and representations that are capable of unlocking untrodden development opportunities. This innovative approach reflects the individual needs of the client and benefits from additional end-points; delivering more data at no additional cost.
RxCelerate’s in vivo services include efficacy, behavioural, pharmacokinetic, pharmacodynamic, safety and preliminary toxicology studies, following dosing with test agent via the oral, intravenous or subcutaneous route.
RxCelerate is a member of LASA and all studies are conducted in accordance with the 3Rs.